Pablo J. Cagnoni, Director at Rubius Therapeutics, Inc. (RUBY), sold 7,240 shares at $0.24 ($2K) on 2023-01-31, disclosed to the SEC on 2023-01-31.
Open-market sale of $2k RUBY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INCY | SELL | 2026-08-14 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-07 | $1.3M | — | Filing → |
| INCY | SELL | 2026-08-04 | $1.9M | — | Filing → |